Julien Veys
Corporate Officer/Principal bei THERANEXUS
Profil
Julien Veys is a professional who has worked as a Chief Business Development Officer at two different companies.
He started working at Trophos SA in 2005 and held the position until 2015.
In 2016, he started working at Theranexus SA, where he currently holds the position of Chief Business Development Officer.
Mr. Veys has a Master's in Business Administration from École des Hautes Études Commerciales de Paris and a graduate degree from Université d'Aix-Marseille.
Aktive Positionen von Julien Veys
| Unternehmen | Position | Beginn |
|---|---|---|
| THERANEXUS | Corporate Officer/Principal | 01.01.2016 |
Ehemalige bekannte Positionen von Julien Veys
| Unternehmen | Position | Ende |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von Julien Veys
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| Université d'Aix-Marseille | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERANEXUS | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
